Company Profiles

driven by the PitchBook Platform

Exosome Diagnostics

Description

Developer of blood-based cancer molecular diagnostics for patient stratification and disease monitoring. The company develops biofluid-based molecular diagnostic tests for use in personalized medicine.

2008

Founded

PRIVATE

Status

11-50

Employees

Series B2

Latest Deal Type

$32.9M

Latest Deal Amount

$87M

Total Amount Raised

Description

Developer of blood-based cancer molecular diagnostics for patient stratification and disease monitoring. The company develops biofluid-based molecular diagnostic tests for use in personalized medicine.

Website:

www.exosomedx.com

Formerly Known As

Exosome Theranostics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

Riverside Technology Center 840 Memorial Drive, Suite 3 Cambridge, MA 02139United States +1 (617) 588-0500
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Exosome Diagnostics's full profile, request a free trial.

Exosome Diagnostics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Exosome Diagnostics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Exosome Diagnostics Investors (12)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Arcus VenturesVenture CapitalMinority000 0000000 0000
Blue Ridge CapitalReal EstateMinority000 0000000 0000
b-to-vVenture CapitalMinority000 0000000 0000
CD-VentureVenture CapitalMinority000 0000000 0000
Forbion Capital PartnersVenture CapitalMinority000 0000000 0000
Arcus Ventures Venture Capital
Blue Ridge Capital Real Estate
b-to-v Venture Capital
CD-Venture Venture Capital
Forbion Capital Partners Venture Capital

Exosome Diagnostics Executive Team (11)

NameTitleBoard
Seat
Contact
Info
John BoyceChief Executive Officer
William KellyChief Financial Officer
Wayne Comper Ph.DCo-Founder & Chief Science Officer
Johan Skog Ph.DChief Scientific Officer & Founding Scientist
Susan BelzerDirector, Development and Services
John Boyce Chief Executive Officer
William Kelly Chief Financial Officer
Wayne Comper Ph.D Co-Founder & Chief Science Officer
Johan Skog Ph.D Chief Scientific Officer & Founding Scientist
Susan Belzer Director, Development and Services

Exosome Diagnostics Board Members (7)

NameRepresentingRoleSinceContact
Info
Daniel ZabrowskiExosome DiagnosticsBoard of Directors000 0000
Geert-Jan Mulder MDForbion Capital PartnersCo-Founding Partner & General Partner000 0000
Joseph BoystakSelfBoard Member & Chairman, Audit Committee000 0000
Joseph SlatterySelfBoard Member000 0000
Kapil Dhingra MDForbion Capital PartnersAdvisor000 0000
Daniel Zabrowski Board of Directors Exosome Diagnostics
Geert-Jan Mulder MD Co-Founding Partner & General Partner Forbion Capital Partners
Joseph Boystak Board Member & Chairman, Audit Committee Self
Joseph Slattery Board Member Self
Kapil Dhingra MD Advisor Forbion Capital Partners
Request full access to PitchBook